Matthew Henn
About Matthew Henn
Matthew Henn is the EVP and Chief Scientific Officer with over 20 years of research experience in microbial ecology, genomics, and bioinformatics, and has significantly contributed to the field of microbiome therapeutics.
Matthew Henn EVP, Chief Scientific Officer
Matthew Henn holds the position of Executive Vice President and Chief Scientific Officer. With over 20 years in research spanning microbial ecology, genomics, and bioinformatics, his role centers on the scientific oversight and development of microbial therapeutics. His expertise in these fields has been integral to his leadership position.
Matthew Henn Education and Expertise
Matthew Henn earned his B.S. in ecology and evolutionary sciences from the University of New Hampshire. He went on to complete his Ph.D. at the University of California, Berkeley, as a NASA Earth Systems Sciences Fellow. Furthermore, he trained as an NSF Postdoctoral Fellow at Duke University. His extensive education underpins his knowledge and leadership in microbial research and development.
Matthew Henn Background in Microbial Research
Prior to helping launch Seres in 2012, Matthew Henn served as the Director of Viral Genomics and Assistant Director of the Genome Sequencing Center for Infectious Diseases at the Broad Institute of MIT and Harvard. His work there significantly contributed to our understanding of viral genomics and infectious diseases. He has also been involved in NIH working groups focused on antimicrobial resistance and microbiome research, showcasing his commitment to advancing the field.
Matthew Henn Achievements in Microbiome Therapeutics
Matthew Henn has been instrumental in the discovery and clinical development of several microbiome therapeutics, including all of Seres Therapeutics' product candidates. He has authored over 65 peer-reviewed publications and has developed genomic and functional tools that have advanced the study of microbial systems. His research highlights the functional roles of microbes in environmental and human disease applications.
Matthew Henn Advisory Roles and Editorial Contributions
Matthew Henn serves on the scientific advisory board of Growcentia, Inc., an agricultural microbiome company. He is also a scientific advisor for NIH's Viral Pathogen Bioinformatics Resource Center. In addition, he has been an ad-hoc reviewer and editor for various peer-reviewed journals, contributing his expertise to the broader scientific community.